second-line pancreatic cancer: nanoliposomal irinotecan
Published 6 years ago • 377 plays • Length 3:27Download video MP4
Download video MP3
Similar videos
-
7:24
pancreas cancer: incorporating nanoliposomal irinotecan
-
1:29
dr. ocean on the development of nanoliposomal irinotecan in metastatic pancreatic cancer
-
3:54
impact of second-line approval of liposomal irinotecan
-
2:39
metastatic pancreas cancer: beyond second-line treatment
-
4:48
liposomal irinotecan in advanced pancreatic cancer
-
4:22
mm-398 for second-line therapy in advanced pancreatic cancer
-
0:53
second-line treatment strategies for pancreatic cancer
-
1:56
eileen m. o'reilly, md: the significance of second-line therapy in pancreatic cancer
-
2:48
george p. kim, md: the significance of second-line therapy in pancreatic cancer
-
4:44
sequencing strategies for metastatic pancreatic cancer
-
1:45
second-line treatment of pancreatic cancer
-
1:12
elucidating the optimal second-line therapy in metastatic pancreatic cancer
-
2:16
efficacy of nanoliposomal irinotecan in biliary tract cancer
-
4:45
relapsed or refractory metastatic pancreatic cancer
-
2:57
frontline options for the treatment of pancreatic cancer
-
4:14
progression of metastatic pancreatic cancer
-
8:08
pancreatic cancer: updated nccn guidelines
-
0:52
neo-nal-iri: liposomal irinotecan 5-fu & oxaliplatin in panceratic cancer
-
0:43
onilon: trifluridine/tipiracil with nanoliposomal irinotecan in advanced crc